潘洪双, 李磊, 崔华博, 杨丽娜, 于婷婷, 孟艳秋. 熊果酸衍生物的合成及初步体外抗肿瘤活性研究J. 药学学报, 2017,52(12): 1890-1894. doi: 10.16438/j.0513-4870.2017-0692
引用本文: 潘洪双, 李磊, 崔华博, 杨丽娜, 于婷婷, 孟艳秋. 熊果酸衍生物的合成及初步体外抗肿瘤活性研究J. 药学学报, 2017,52(12): 1890-1894. doi: 10.16438/j.0513-4870.2017-0692
PAN Hong-shuang, LI Lei, CUI Hua-bo, YANG Li-na, YU Ting-ting, MENG Yan-qiu. Synthesis and anti-tumor activity of derivatives of ursolic acid in vitroJ. Acta Pharmaceutica Sinica, 2017,52(12): 1890-1894. doi: 10.16438/j.0513-4870.2017-0692
Citation: PAN Hong-shuang, LI Lei, CUI Hua-bo, YANG Li-na, YU Ting-ting, MENG Yan-qiu. Synthesis and anti-tumor activity of derivatives of ursolic acid in vitroJ. Acta Pharmaceutica Sinica, 2017,52(12): 1890-1894. doi: 10.16438/j.0513-4870.2017-0692

熊果酸衍生物的合成及初步体外抗肿瘤活性研究

Synthesis and anti-tumor activity of derivatives of ursolic acid in vitro

  • 摘要: 以熊果酸为先导化合物,在其A环骈合4-氯吲哚环,同时对C-28位进行成酯、酰胺化等结构修饰,设计合成了两类共10个新型熊果酸A环衍生物,其结构经1H NMR、MS等确认。采用MTT法,选用人肝癌细胞(HepG2)和人胃癌细胞(SGC7901)对所得化合物进行初步的体外抗肿瘤活性测试。结果表明,所测化合物对HepG2、SGC7901肿瘤细胞的抑制作用均强于母体熊果酸,尤其是化合物612表现出较为显著的抗肿瘤活性,与已上市药物紫杉醇活性相当,值得进一步研究。

     

    Abstract: A series of ursolic acid derivatives were synthesized by the introduction of 4-chloroindole compounds at A ring and esterification and amidation at C-28 position, which structures were characterized by 1H NMR, MS and etc. The cytotoxic activity of derivatives was evaluated against HepG2 and SGC7901 cells in vitro by MTT assay, in which paclitaxel and adriamycin were used as a positive control. The results indicated that all of derivatives can inhibit cell proliferation in HepG2 and SGC7901 cells with a better activity than ursolic acid. Especially, the compounds 6 and 12 showed significant antitumor activity comparable to the paclitaxel. The compounds are worthy to be studied further.

     

/

返回文章
返回